Search research articles
Contact Us
Filters
Showing results (251-260 of 425) with videos related to
Page
of 43
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 8, 2024
CDKN2A/B Homozygous Deletion Sensitizes IDH-Mutant Glioma to CDK4/6 Inhibition
Ali M Nasser, Lisa Melamed, Ethan A Wetzel, et al.
Neurosurgical Focus
|
February 1, 2024
Suppression of antitumor immune signatures and upregulation of VEGFA as IDH-mutant gliomas progress to higher grade
Eric P Grewal, Leland G K Richardson, Jing Sun, et al.
Neuro-Oncology
|
July 26, 2020
Sirtuin activation targets IDH-mutant tumors
Julie J Miller, Alexandria Fink, Jack A Banagis, et al.
The Journal of Biological Chemistry
|
June 16, 2023
SAMHD1 impairs type I interferon induction through the MAVS, IKKε, and IRF7 signaling axis during viral infection
Constanza E Espada, Levent Sari, Michael P Cahill, et al.
Journal of Neuro-Oncology
|
April 30, 2014
Diagnostic discrepancies in malignant astrocytoma due to limited small pathological tumor sample can be overcome by IDH1 testing
Betty Y S Kim, Wen Jiang, Jason Beiko, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
June 24, 2020
Adult-Born Hippocampal Neurons Undergo Extended Development and Are Morphologically Distinct from Neonatally-Born Neurons
John Darby Cole, Delane F Espinueva, Désirée R Seib, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia
|
June 10, 2016
Impact of histopathological transformation and overall survival in patients with progressive anaplastic glioma
Allen L Ho, Matthew J Koch, Shota Tanaka, et al.
Acta Neuropathologica Communications
|
May 1, 2019
PIK3CA activating mutations are associated with more disseminated disease at presentation and earlier recurrence in glioblastoma
Shota Tanaka, Tracy T Batchelor, A John Iafrate, et al.
Seminars in Radiation Oncology
|
June 7, 2020
Repeat Radiation in the Brain: Managing Patients With Locally Recurrent Glioma
Daniel M Trifiletti, Timothy D Malouff, Susan L McGovern, et al.
Journal of Neuro-Oncology
|
December 12, 2018
Radiographic assessment of contrast enhancement and T2/FLAIR mismatch sign in lower grade gliomas: correlation with molecular groups
Tareq A Juratli, Shilpa S Tummala, Angelika Riedl, et al.
Page
of 43
Search research articles
Search
Showing results (251-260 of 425) with videos related to
Sort By:
Page
of 43
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 8, 2024
CDKN2A/B Homozygous Deletion Sensitizes IDH-Mutant Glioma to CDK4/6 Inhibition
Ali M Nasser, Lisa Melamed, Ethan A Wetzel, et al.
Neurosurgical Focus
|
February 1, 2024
Suppression of antitumor immune signatures and upregulation of VEGFA as IDH-mutant gliomas progress to higher grade
Eric P Grewal, Leland G K Richardson, Jing Sun, et al.
Neuro-Oncology
|
July 26, 2020
Sirtuin activation targets IDH-mutant tumors
Julie J Miller, Alexandria Fink, Jack A Banagis, et al.
The Journal of Biological Chemistry
|
June 16, 2023
SAMHD1 impairs type I interferon induction through the MAVS, IKKε, and IRF7 signaling axis during viral infection
Constanza E Espada, Levent Sari, Michael P Cahill, et al.
Journal of Neuro-Oncology
|
April 30, 2014
Diagnostic discrepancies in malignant astrocytoma due to limited small pathological tumor sample can be overcome by IDH1 testing
Betty Y S Kim, Wen Jiang, Jason Beiko, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
June 24, 2020
Adult-Born Hippocampal Neurons Undergo Extended Development and Are Morphologically Distinct from Neonatally-Born Neurons
John Darby Cole, Delane F Espinueva, Désirée R Seib, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia
|
June 10, 2016
Impact of histopathological transformation and overall survival in patients with progressive anaplastic glioma
Allen L Ho, Matthew J Koch, Shota Tanaka, et al.
Acta Neuropathologica Communications
|
May 1, 2019
PIK3CA activating mutations are associated with more disseminated disease at presentation and earlier recurrence in glioblastoma
Shota Tanaka, Tracy T Batchelor, A John Iafrate, et al.
Seminars in Radiation Oncology
|
June 7, 2020
Repeat Radiation in the Brain: Managing Patients With Locally Recurrent Glioma
Daniel M Trifiletti, Timothy D Malouff, Susan L McGovern, et al.
Journal of Neuro-Oncology
|
December 12, 2018
Radiographic assessment of contrast enhancement and T2/FLAIR mismatch sign in lower grade gliomas: correlation with molecular groups
Tareq A Juratli, Shilpa S Tummala, Angelika Riedl, et al.
Page
of 43